ArticleJournal of gastric cancer2023

A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation.

Guk Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.